Lv1
40 积分 2025-05-16 加入
SMARCA4 Deficiency in Lung Cancer: From Signaling Pathway to Potential Therapeutic Targets
7小时前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
1个月前
已完结
Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC)
1个月前
已完结
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
1个月前
已完结
Small cell lung cancer transformation: From pathogenesis to treatment
2个月前
已完结
Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study
2个月前
已完结
A potential treatment option for transformed small-cell lung cancer on PD-L1 inhibitor-based combination therapy improved survival
2个月前
已完结
Abstract 1137: Identification of a high selective SMARCA2 degrader which effectively suppresses the SMARCA4-deficient tumors in vitro and in vivo
4个月前
已关闭
Clinicopathologic Characteristics of BRG1-Deficient NSCLC
4个月前
已完结
Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden
4个月前
已完结
皖公网安备34019202002308
